Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,810 public trials 143 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Not Yet Recruiting

Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals

NCT07712042

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations: Qianfoshan Hospital Ji'nan, China

View Trial Details

Not Yet Recruiting

Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health

NCT07662616

Conditions: Body Weight, Cardiovascular Diseases, Cardiovascular-kidney-metabolic (CKM), +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

NCT07693777

Conditions: Digestive System Diseases, Dyslipidemias, Fatty Liver, +10 more
Locations: Zhongshan Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia

NCT07680829

Conditions: Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations: Peking University First Hospital Beijing, China

Peking University People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

NCT07684469

Conditions: Acute Coronary Syndrome, Cardiovascular Diseases, Dyslipidemias, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

NCT07674524

Conditions: ALK Gene Mutation, ALK-positive, Bronchial Neoplasms, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia

NCT07657780

Conditions: Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Not Yet Recruiting

Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP

NCT07653555

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

NCT07619131

Conditions: Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

NCT07617155

Conditions: Chronic Disease, Digestive System Diseases, Disease Attributes, +14 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details